Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease (Q57396337)

From Wikidata
Jump to navigation Jump to search
article
edit
Language Label Description Also known as
English
Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease
article

    Statements

    Rationale—Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT): Evolving the management of cardiovascular risk in patients with chronic kidney disease (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    T.-Christian H. Mix
    0 references
    Robert M. Brenner
    0 references
    Mark E. Cooper
    0 references
    Dick de Zeeuw
    0 references
    Peter Ivanovich
    0 references
    Brian J.G. Pereira
    0 references
    Ajay K. Singh
    0 references
    Scott D. Solomon
    0 references
    Catherine Stehman-Breen
    0 references
    March 2005
    0 references
    149
    0 references
    3
    0 references
    408-413
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit